Pure Global AI
NCT06290921Recruitment Completed

Ovulation Triggering 2 vs 3 Follicles

Ovulation Trigger With Less Than 3 Follicles in Stimulated In-vitro Fertilization (IVF) Cycles
Clinique OvoClinicalTrials.govother
Study focus
Disease/Condition
Infertility
Drug/Device/Intervention
Ovulation triggering
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Clinique Ovo
Location
Montréal, Canada
Timeline & enrollment
Phase
N/A
Start date
Feb 22, 2024
End date
Feb 20, 2025
Enrollment
400 participants
Primary outcome

Clinical Pregnancy Rate

Summary

Poor responders in in-vitro fertilization (IVF) cycles represent a major challenge for
 fertility specialists. Although poor responders tend to have sub-optimal fertility treatment
 outcomes, many of these patients wish to attempt at least one IVF cycle. Traditionally, IVF
 cycles producing less than 3 to 4 mature follicles (measuring at least 14 mm) have either
 been cancelled or converted to intra-uterine insemination (IUI) due to the low pregnancy
 rates associated with these cycles. The minimal number of follicles required to proceed with
 egg collection is based on clinical experience, having been determined by weighing the
 probability of implantation and pregnancy versus the risk of not obtaining quality oocytes or
 reaching embryo transfer when fewer mature follicles are present. This retrospective quality
 control study aims to compare pregnancy rates in IVF cycles producing 3 follicles measuring
 14 mm and more on trigger day, versus 2 or fewer follicles.

ICD-10 classifications
Female infertilityMale infertilityFemale infertility, unspecifiedFemale infertility of other originFemale infertility of uterine origin
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06290921
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06290921 through Pure Global AI's free database. This phase not specified trial is sponsored by Clinique Ovo and is currently Recruitment Completed. The study focuses on Infertility. Target enrollment is 400 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.